Medical Equipment Stocks' Research Reports Released on Medtronic, Edwards Lifesciences, Globus Medical, and Invacare

Thursday, January 4, 2018 Medical Gadgets
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Jan. 4, 2018 /PRNewswire/ -- strives to bring the best free research to the investment

community.  Today we are offering reports on MDT, EW, GMED, and IVC which can be accessed for free by signing up to On Wednesday, the NASDAQ Composite ended the day at 7,065.53, up 0.84%; the Dow Jones
Industrial Average edged 0.40% higher, to finish at 24,922.68; and the S&P 500 closed at 2,713.06, marginally gaining 0.64%. Gains were broad based as eight out of nine sectors finished the trading session in green. has initiated research reports on the following Medical Appliances & Equipment stocks: Medtronic PLC (NYSE: MDT), Edwards Lifesciences Corp. (NYSE: EW), Globus Medical Inc. (NYSE: GMED), and Invacare Corp. (NYSE: IVC). All you have to do is sign up today for this free limited time offer by clicking the link below.


Dublin, Ireland headquartered Medtronic PLC's stock finished Wednesday's session 2.08% higher at $83.92 with a total trading volume of 6.88 million shares, which was above its three months average volume of 5.44 million shares. The stock has gained 18.85% in the previous twelve months. The Company's shares are trading above their 50-day and 200-day moving averages by 4.06% and 1.84%, respectively. Moreover, shares of Medtronic, which manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide, have a Relative Strength Index (RSI) of 63.43.

On January 03rd, 2018, research firm Evercore ISI initiated an 'Outperform' rating on the Company's stock, with a target price of $92.50 per share. Get the full research report on MDT for free by clicking below at:

Edwards Lifesciences

Shares in Irvine, California headquartered Edwards Lifesciences Corp. rose 2.70%, ending yesterday's session at $114.59 with a total trading volume of 1.27 million shares. The stock has gained 19.96% over the past twelve months. The Company's shares are trading above their 50-day and 200-day moving averages by 4.07% and 3.71%, respectively. Moreover, shares of Edwards Lifesciences, which provides products and technologies to treat structural heart disease and critically ill patients worldwide, have an RSI of 57.35.

On January 03rd, 2018, research firm Evercore ISI initiated an 'Outperform' rating on the Company's stock, with a target price of $140 per share. Gain free access to the research report on EW at:

Globus Medical

On Wednesday, Audubon, Pennsylvania headquartered Globus Medical Inc.'s stock saw a decline of 0.63%, to close the day at $42.9. A total volume of 601,151 shares was traded. The Company's shares have advanced 14.04% in the last month, 41.49% in the previous three months, and 73.05% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 17.28% and 33.09%, respectively. Additionally, shares of Globus Medical, which focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders, have an RSI of 74.36.

On January 02nd, 2018, research firm Morgan Stanley upgraded the Company's stock rating from 'Equal-Weight' to 'Overweight'. Register for your free report coverage on GMED at:


Shares in Elyria, Ohio headquartered Invacare Corp. ended the day 1.46% higher at $17.40. A total volume of 324,992 shares was traded. The stock has gained 10.83% in the previous three months and 33.33% over the last twelve months. The Company's shares are trading above their 50-day and 200-day moving averages by 4.08% and 20.55%, respectively. Furthermore, shares of Invacare, which together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide, have an RSI of 58.59. Get the free research report on IVC at:


Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

WSE has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit


For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: Phone number: +21-32-044-483Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


Cision View original content:

SOURCE Wall St. Equities


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store